Abstract
Quantitative structure-activity relationship study was performed to understand the inhibitory activity of a set of 192 vascular endothelial growth factor receptor-2 (VEGFR-2) compounds. QSAR models were developed using multiple linear regression (MLR) and partial least squares (PLS) as linear methods. While principal component - artificial neural networks (PC-ANN) modeling method with application of eigenvalue ranking factor selection procedure was used as nonlinear method. The results obtained offer good regression models having good prediction ability. The results obtained by MLR and PLS are close and better than those obtained by principal component- artificial neural network. The best model was obtained with a correlation coefficient of 0.87. The strength and the predictive performance of the proposed models was verified using both internal (cross-validation and Y-scrambling) and external statistical validations.
Keywords: Vascular endothelial growth factor receptor-2 (VEGFR-2), quantitative structure-activity relationship, Principal component artificial neural network (PC-ANN), Multiple linear regression (MLR) and Partial least square (PLS), prediction ability, correlation coefficient, cross-validation, Y-scrambling
Current Pharmaceutical Design
Title:Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN
Volume: 19 Issue: 12
Author(s): Omar Deeb, Sana Jawabreh and Mohammad Goodarzi
Affiliation:
Keywords: Vascular endothelial growth factor receptor-2 (VEGFR-2), quantitative structure-activity relationship, Principal component artificial neural network (PC-ANN), Multiple linear regression (MLR) and Partial least square (PLS), prediction ability, correlation coefficient, cross-validation, Y-scrambling
Abstract: Quantitative structure-activity relationship study was performed to understand the inhibitory activity of a set of 192 vascular endothelial growth factor receptor-2 (VEGFR-2) compounds. QSAR models were developed using multiple linear regression (MLR) and partial least squares (PLS) as linear methods. While principal component - artificial neural networks (PC-ANN) modeling method with application of eigenvalue ranking factor selection procedure was used as nonlinear method. The results obtained offer good regression models having good prediction ability. The results obtained by MLR and PLS are close and better than those obtained by principal component- artificial neural network. The best model was obtained with a correlation coefficient of 0.87. The strength and the predictive performance of the proposed models was verified using both internal (cross-validation and Y-scrambling) and external statistical validations.
Export Options
About this article
Cite this article as:
Deeb Omar, Jawabreh Sana and Goodarzi Mohammad, Exploring QSARs of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Tyrosine Kinase Inhibitors by MLR, PLS and PC-ANN, Current Pharmaceutical Design 2013; 19 (12) . https://dx.doi.org/10.2174/1381612811319120010
DOI https://dx.doi.org/10.2174/1381612811319120010 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Focus on MicroRNAs as Biomarker in Pediatric Diseases
Current Pharmaceutical Design HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study
Current Drug Targets Chinese Medicinal Herbs as Source of Antioxidant Compounds – Where Tradition Meets the Future
Current Medicinal Chemistry Isolation of Achyrobichalcone from Achyrocline satureioides by High- Speed Countercurrent Chromatography
Current Pharmaceutical Biotechnology Aptamers: Potential Applications to Pancreatic Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges
Current Drug Targets Hybrid Pharmacophore Design and Synthesis of Naphthalimide– Benzimidazole Conjugates as Potential Anticancer Agents
Letters in Drug Design & Discovery Lycopene and Cardiovascular Diseases: An Update
Current Medicinal Chemistry Pretargeted Radioimmunotherapy with α-Particle Emitting Radionuclides
Current Radiopharmaceuticals Subcellular Analysis of the Platelet Proteome
Current Proteomics Age-Dependent Changes of the temporal Order - Causes and Treatment
Current Aging Science 2D QSAR Studies on a Series of Quinazoline Derivatives as Tyrosine Kinase (EGFR) Inhibitor: An Approach to Design Anticancer Agents
Letters in Drug Design & Discovery CH50: A Revisited Hemolytic Complement Consumption Assay for Evaluation of Nanoparticles and Blood Plasma Protein Interaction
Current Drug Delivery Radiosynthesis of 2-deoxy-2-[18F]fluorothymidine ([18F]FT), a Putative PET Agent for Imaging HSV-TK Expression
Current Radiopharmaceuticals Exogenous Hormonal Regulation in Breast Cancer Cells by Phytoestrogens and Endocrine Disruptors
Current Medicinal Chemistry The Role of Atomic Spectrometric Techniques in the Determination of Chemical Elements in Atmospheric Aerosols
Current Analytical Chemistry Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) – an Introduction for Biologists
Current Proteomics Antioxidant Capacity and Identification of Bioactive Compounds by GC-MS of Essential Oils from Spices, Herbs and Citrus
Current Bioactive Compounds Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Recent Patents on Anti-Cancer Drug Discovery Proteomics Approach to Illustrate Drug Action Mechanisms
Current Drug Discovery Technologies